CD8A and neoplasm: Also, specificities of analyzed biomarkers in melanoma tumor microenvironment cells were very good for PD-L1 (TILs: 91.67%; M: 96.97%), CD8 (86.67%), CD4 (90.00%, p < 0.001) (Table 3, Figure 6).